Satellos Bioscience Inc (MSLE)

May 01, 2026

MSLE Stock Price, Quote & Chart | SATELLOS BIOSCIENCE INC (NASDAQ:MSLE) - ChartMill

May 01, 2026

Apr 28, 2026

Guggenheim Initiates Satellos Bioscience(MSLE.US) With Buy Rating, Announces Target Price $23 - Moomoo

Apr 28, 2026

Apr 27, 2026

Satellos launches public offering, applies for Nasdaq listing - MSN

Apr 27, 2026

Apr 25, 2026

Satellos Bioscience (NASDAQ:MSLE) Downgraded by Wall Street Zen to "Strong Sell" - MarketBeat

Apr 25, 2026

Apr 23, 2026

Satellos prices $50M public offering - MSN

Apr 23, 2026

Apr 22, 2026

MSLE Satellos Bioscience Inc. reports far wider than expected Q4 2025 loss while its shares post modest gains amid positive investor sentiment.Viral Momentum Stocks - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 20, 2026

Satellos Bioscience (MSLE) Stock: Portfolio Allocation (Bearish Sentiment) 2026-04-20Community Chart Signals - Xã Châu Thành

Apr 20, 2026

Apr 12, 2026

MSLE : Satellos Bioscience Inc. Key Company Metrics & Non-finance Metrics - Zacks Investment Research

Apr 12, 2026

Apr 12, 2026

MSLE: Satellos Bioscience Inc.Insider Transations - Zacks Investment Research

Apr 12, 2026

Apr 09, 2026

Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference - Investing News Network

Apr 09, 2026

Apr 09, 2026

Satellos Bioscience to Showcase DMD Program at April Bloom Burton Healthcare Investor Conference - TipRanks

Apr 09, 2026

Apr 09, 2026

Satellos Bioscience (NASDAQ: MSLE) plans Bloom Burton investor conference presentation - Stock Titan

Apr 09, 2026

Apr 09, 2026

Satellos CEO, CFO to meet investors in Toronto on April 21 - Stock Titan

Apr 09, 2026

Apr 07, 2026

Satellos Bioscience (NASDAQ:MSLE) Coverage Initiated by Analysts at Leerink Partners - Defense World

Apr 07, 2026

Apr 06, 2026

Satellos Bioscience Inc. (NASDAQ:MSLE) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Apr 06, 2026

Apr 06, 2026

Satellos Bioscience (NASDAQ:MSLE) Now Covered by Analysts at Leerink Partners - MarketBeat

Apr 06, 2026

Apr 06, 2026

Leerink initiates Satellos Bioscience stock with Outperform rating By Investing.com - Investing.com South Africa

Apr 06, 2026

Apr 06, 2026

MSLE Archives - 24/7 Wall St.

Apr 06, 2026

Apr 06, 2026

Leerink initiates Satellos Bioscience stock with Outperform rating - Investing.com

Apr 06, 2026

Apr 06, 2026

Satellos initiated with an Outperform at Leerink - TipRanks

Apr 06, 2026

Apr 06, 2026

Investment bank Leerink Partners recently released a research report, initiating coverage on biotechnology company Satellos Bioscience Inc. (stock symbol: MSLE) for the first time. - Bitget

Apr 06, 2026

Apr 03, 2026

Satellos Bioscience Inc. (0IT.SG) Options Chain - Yahoo! Finance Canada

Apr 03, 2026

Apr 03, 2026

All News for MSLE : Satellos Bioscience Inc. - Zacks Investment Research

Apr 03, 2026

Apr 03, 2026

MSLE Stock Analysis: Satellos Bioscience Inc. 2.81 pct dip to 5.87 key insights - Cổng thông tin điện tử tỉnh Lào Cai

Apr 03, 2026

Apr 02, 2026

What date does Satellos Bioscience Inc.'s (MSLE) report EarningsEarnings Calendar & Announcement - zacks.com

Apr 02, 2026

Apr 01, 2026

Long Term Trading Analysis for (MSCL) (MSCL:CA) - Stock Traders Daily

Apr 01, 2026

Apr 01, 2026

Brokers Offer Predictions for MSLE FY2030 Earnings - Defense World

Apr 01, 2026

Mar 31, 2026

FY2030 Earnings Forecast for MSLE Issued By HC Wainwright - MarketBeat

Mar 31, 2026

Mar 31, 2026

Dividend HistorySatellos Bioscience Inc. (MSLE) - Zacks Investment Research

Mar 31, 2026

Mar 30, 2026

Satellos Bioscience: 2025 Financial Performance - AlphaStreet

Mar 30, 2026

Mar 28, 2026

Satellos Bioscience (NASDAQ:MSLE) Releases Earnings Results - MarketBeat

Mar 28, 2026

Mar 27, 2026

Stocks in play: Satellos Bioscience Inc. - Barchart

Mar 27, 2026

Mar 27, 2026

Satellos Bioscience Posts 2025 Results, Advances SAT-3247 Into Global Phase 2 Duchenne Trials - TipRanks

Mar 27, 2026

Mar 27, 2026

Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 27, 2026

Mar 27, 2026

Satellos Bioscience: Q4 Earnings Snapshot - marketscreener.com

Mar 27, 2026

Mar 27, 2026

Satellos Bioscience : Fourth Quarter 2025 Management’s Discussion Analysis - marketscreener.com

Mar 27, 2026

Mar 27, 2026

Satellos Bioscience (NASDAQ: MSLE) files annual report; 15,458,903 shares - Stock Titan

Mar 27, 2026

Mar 27, 2026

Satellos Bioscience (MSLE) funds 2027 runway while advancing Phase 2 DMD trials - Stock Titan

Mar 27, 2026

Mar 27, 2026

Satellos Reports 2025 Financial Results and Highlights Recent Company Progress - 富途牛牛

Mar 27, 2026

Mar 23, 2026

MSLE Earnings History & Surprises | EPS & Revenue Results | SATELLOS BIOSCIENCE INC (NASDAQ:MSLE) - ChartMill

Mar 23, 2026

Mar 23, 2026

MSLE News | SATELLOS BIOSCIENCE INC (NASDAQ:MSLE) - ChartMill

Mar 23, 2026

Mar 18, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mar 18, 2026

Mar 14, 2026

Satellos Bioscience (NASDAQ:MSLE) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat

Mar 14, 2026

Mar 13, 2026

Cantor Fitzgerald Initiates Coverage on Satellos Bioscience (NASDAQ:MSLE) - Defense World

Mar 13, 2026

Mar 12, 2026

(MSCL) Comprehensive Trading Strategy Report (MSCL:CA) - Stock Traders Daily

Mar 12, 2026

Mar 12, 2026

This Canadian biotech stock will beat the market, analyst says - Cantech Letter

Mar 12, 2026

Mar 11, 2026

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga

Mar 11, 2026